Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Human term placenta a new abundant source of hematopoietic cells

Human term placenta a new abundant source of hematopoietic cells

June 25, 2009

Investigators at Children's Hospital Oakland Research Institute, Oakland, California found a way to obtain large numbers of hematopoietic stem cell from human term placenta. The results, which appear in the July 2009 issue of Experimental Biology and Medicine, describe detailed report on quantification, characterization, engraftment capacity, and most importantly, practical way to obtain hematopoietic stem cells from placenta in numbers that are several-fold higher than could be obtained from cord blood.

The research team, Dr. Vladimir Serikov, MD, PhD, D.Sci, Assistant Staff Scientist, Catherin Hounshell, a research associate, Sandra Larkin, a research associate, Mr. William Green, student, Dr. Hurokazy Ikeda, MD, Visiting Scientist, Dr. Mark Walters, Medical Director of Children's Hospital Oakland Hematology and Oncology Programs, and Dr. Frans Kuypers, Senior Scientist, performed studies in human term placentas, human cord blood, and immunodeficient mice. Dr. Serikov said, that the fact the human term placenta is a hematopoietic organ was reported by our team for the first time more then a year ago, and this year this finding was confirmed by UCSF scientists headed by Dr. S. Fisher.




In this report, said Dr. Serikov, we demonstrate for the first time that human placentas could provide abundant amounts of CD34+ CD133+ colony-forming cells, as well as other primitive hematopoietic progenitors, suitable for transplantation in humans. The total amount of live hematopoitic stem cells, or colony-forming units in culture that could be obtained from placentas was an order of magnitude larger than the number of hematopoietic stem cells obtained from cord blood from the same source. Hematopoietic stem cells which maintain their differentiation capacity, as well as stromal stem cells that support long-term culture of hematopoietic cells, can be harvested from perfusate of placenta following CXCR4 receptor blockade, said Dr. F. Kuypers. Importantly, live HPCs can similarly be obtained from whole cryopreserved placentas. Cells derived from placental tissue differentiated into all blood lineages in vitro. Animal experiments further demonstrated successful engraftment of placenta-derived HSC, which reconstituted hematopoiesis in immunodeficient mice.

In summary, said Dr. F. Kuypers, our results indicate for the first time that human term placenta is a high capacity source of live and functional hematopoietic stem cells. By using placental circulation and stem cell receptor blockade an abundant amounts of hematopoietic stem cell could be easily obtained in sterile conditions by non-destructive methods.

Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine said "the outstanding importance of these results for practical hematology is determined by the fact that total number of stem cells that can be harvested from cord blood limits the efficacy of this stem cell source for transplants only to small children. These novel findings demonstrate that placenta may provide a source of autologous stem cells sufficient for reconstitution of hematopoiesis in adult patients. Use of methods to obtain hematopoietic cells from placenta, developed by Dr. Serikov and Dr. Kuypers as augumentation of cord blood-based therapy or replacement of bone marrow for transplantation will dramatically change whole field of transplantology."

Society for Experimental Biology and Medicine



Related Hematopoietic Current Events and Hematopoietic News Articles Hematopoietic Current Events and Hematopoietic News RSS Hematopoietic Current Events and Hematopoietic News RSS
Immune therapy can protect against or treat later lymphoma
Specially developed immune system cells that target the common Epstein-Barr virus can protect immune-suppressed bone marrow transplant recipients against lymph system disease and cancers that arise from the viral infection.

Immunotherapy demonstrates long-term success in treating lymphoma
Targeted immunotherapy has been an attractive new therapeutic area for a number of cancers because it has the potential to destroy tumor cells without damaging surrounding normal tissue. New study results demonstrate high success rates using specialized white blood cells to prevent or treat lymphoma associated with the Epstein-Barr virus (EBV-lymphoma) in patients who have received a hematopoietic stem cell transplant (HSCT).

MDC scientists show how hematopoietic stem cell development is regulated
During cell division, whether hematopoietic stem cells (HSCs) will develop into new stem cells (self-renewal) or differentiate into other blood cells depends on a chemical process called DNA methylation.

New research strategy for understanding drug resistance in leukemia
UCSF researchers have developed a new approach to identify specific genes that influence how cancer cells respond to drugs and how they become resistant. This strategy, which involves producing diverse genetic mutations that result in leukemia and associating specific mutations with treatment outcomes, will enable researchers to better understand how drug resistance occurs in leukemia and other cancers, and has important long-term implications for the development of more effective therapies.

Mother's immune system may block fetal treatments for blood diseases
Pediatric researchers have resolved an apparent contradiction in the field of prenatal cell transplantation- a medical approach that holds future promise in correcting sickle cell disease and other serious congenital blood disorders.

Methods for gene transfer in stem cells featured in Cold Spring Harbor Protocols
Vectors derived from retroviruses are useful tools for long-term gene transfer because they allow stable integration of transgenes and propagation into daughter cells.

Comprehensive look at rare leukemia finds relatively few genetic changes launch disease
The most comprehensive analysis yet of the genome of childhood acute myeloid leukemia (AML) found only a few mistakes in the genetic blueprint, suggesting the cancer arises from just a handful of missteps.

MGH study identifies first molecular steps to childhood leukemia
A Massachusetts General Hospital (MGH)-based research team has identified how a chromosomal abnormality known to be associated with acute lymphoblastic leukemia (ALL) - the most common cancer in children - initiates the disease process.

What do blood stem cells need to grow? Blood flow
Blood stem cells literally go with the flow, according to a new report published as an immediate early publication in the journal Cell, a Cell Press journal, on May 13th.

Embryo's heartbeat drives blood stem cell formation
Biologists have long wondered why the embryonic heart begins beating so early, before the tissues actually need to be infused with blood.
More Hematopoietic Current Events and Hematopoietic News Articles
Thomas' Hematopoietic Cell Transplantation (Thomas Hematopoietic Cell Transplantation)

Thomas' Hematopoietic Cell Transplantation (Thomas Hematopoietic Cell Transplantation)
by Frederick R. Appelbaum (Editor), Stephen J Forman (Editor), Robert S. Negrin (Editor), Karl G. Blume (Editor)

This outstanding reference source on bone marrow transplantation has become recognised as the bible in the field. This fourth edition has been fully revised to reflect latest developments, and now features over 500 illustrations, including a colour plate section. The need for this new edition cannot be overstated - more than 13,000 new cases per year of haematopoietic stem cell transplantation have been reported to the International Bone Marrow Transplant Registry

The original editor, Donnall Thomas, was a pioneer in stem cell research and won the 1990 Nobel Prize for his discoveries concerning organ and cell transplantation in the treatment of human diseases.

The book also now includes a fully searchable CD with PDFs of the entire content.

  Hematopoietic System
by DigitalMed Corporation

Hematopoietic System is the most comprehensive and interactive software available for the assessment and analysis of blood values and related systemic conditions.

Hematopoietic Stem Cell Protocols (Methods in Molecular Biology)

Hematopoietic Stem Cell Protocols (Methods in Molecular Biology)
by Kevin D. Bunting (Editor)

With new technologies emerging and old technologies being reimagined, the field of hematopoietic stem cell (HSC) research continues to grow rapidly in pursuit of improved therapies for many blood diseases. Updating and building upon the thorough first edition's foundation, Hematopoietic Stem Cell Protocols, Second Edition provides up-to-date protocols developed in the HSC field. A team of leading researchers supply this volume with in-depth, readily reproducible methods for effective characterization of HSC and their developmental potential. An introductory chapter also hints at potential techniques that may develop in the future. Following the format of the successful Methods in Molecular Biology™ series, each protocol offers step-by-step laboratory instructions, lists of the...

  Hematopoietic Stem Cell Transplantation: A Manual for Nursing Practice
by S. Ezzone (Editor)

This new resource is your complete guide to the ever-evolving specialty of hematopoietic stem cell transplantation (HSCT). You will find an array of topics reflecting the continued growth of the specialty including the history of transplantation, stem cell collection, the development of an HSCT program, graft versus host disease, post-transplant follow-up, and more.

Recognizing Skin Signs of Systematic Disease/High-Dose Chemotherapy with Autologous Hematopoietic Progenitor Cell Support for the Treatment of Breast Cancer (NCME Video 689)

Recognizing Skin Signs of Systematic Disease/High-Dose Chemotherapy with Autologous Hematopoietic Progenitor Cell Support for the Treatment of Breast Cancer (NCME Video 689)
Also With: Irwin W. Braverman (Primary Contributor), Elizabeth J. Shpall (Primary Contributor)



Hematopoietic Stem Cell Transplantation: A Handbook for Clinicians

Hematopoietic Stem Cell Transplantation: A Handbook for Clinicians
by American Association of Blood Banks (AABB) (Author), John R. Wingard (Editor), MD (Editor), Dennis A. Gastineau (Editor), Helen L. Leather (Editor), BPharm (Editor), Edwards Snyder (Editor), MD FACP (Editor), Zbigniew M. Szczepiorkowski (Editor), MD PhD (Editor), FCAP (Editor)

Chapters in this easy-to-use guide reflect the combined expertise of practitioners from the Dana-Farber, M.D. Anderson, Memorial Sloan-Kettering, Fred Hutchinson, and other notable cancer centers; from the National Cancer Institute and NMDP; and from numerous respected university programs and medical institutions.

The aim of this HSCT Handbook is to broadly cover the major topics of indications for transplantation; donor and patient evaluation; conditioning regimens; collection, processing, and characterization of stem cell products; management of immunosuppressive therapy; evaluation and management of the myriad complications encountered; suggestions for supportive care; performance of the most common procedures; and aspects of follow-up care. The Handbook s emphasis is on...

Hematopoietic Stem Cell Protocols (Methods in Molecular Medicine)

Hematopoietic Stem Cell Protocols (Methods in Molecular Medicine)
by Christopher A. Klug (Editor), Craig T. Jordan (Editor)

Univ. of Alabama, Birmingham. Offers a wide variety of step-of-step methods for studying hematopoietic stem cells. Details methods for the purification and genetic modification of stem cells and includes stem cell expansion protocols. DNLM: Hematopoietic Stem Cells--cytology.

Practical Hematopoietic Stem Cell Transplantation

Practical Hematopoietic Stem Cell Transplantation
by Andrew J. Cant (Editor), Angela Galloway (Editor), Graham Jackson (Editor)

Practical Hematopoietic Stem Cell Transplantation is the only comprehensive yet practical guide to the total care of the transplant patient. It provides a ready source of reference to help health care professionals involved in the management of patients requiring bone marrow and stem cell transplantations – covering many of the infections and complications that may arise.

An essential, practical manual for all those working in the field of bone marrow and stem cell transplantation

A balanced practical text aimed at the whole multi-disciplinary team
Easy to use - practically organized - covering all aspects of pre and post transplant care – including social and psychological aspects
Experienced and well respected editorial team

Whether you are an established...

Therapy of Hematopoietic Neoplasia (Hematology)

Therapy of Hematopoietic Neoplasia (Hematology)
by Emil J. Freireich (Editor)

Updates current knowledge on the basic science of therapeutics and its influence on treatment choices for tumors arising in the myeloid and lymphoid organs. Among the topics: therapy for acute myelogenous leukemia, classification and management of myelodysplastic syndromes, adults with acute lympho-

Hematopoietic Stem Cell Transplantation (Contemporary Hematology)

Hematopoietic Stem Cell Transplantation (Contemporary Hematology)
by Robert J. Soiffer (Editor)

Remarkable developments in the field of transplantation have created opportunities to address the formidable challenges of transplantation across histocompatibility barriers, stem cell expansion, and prevention of complications and generation of graft-vs-tumor activity to eradicate residual disease. "Stem Cell Transplantation for Hematologic and Other Disorders, Second Edition" provides a glimpse into potential future applications of bone marrow derived stem cells in the field of cardiac repair. The updated chapters introduce the biologic underpinnings of hematopoietic cell transplantation, basic stem cell biology, immunobiology, and histocompatibility, with emphasis on indications and results of transplantation for specific diseases. Written by experts in the field, "Stem Cell...

© 2009 BrightSurf.com